Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.016 AUD | -23.81% | -15.79% | -42.86% |
Apr. 23 | Opyl to Divest Opin Business | MT |
Mar. 22 | Opyl Receives Offer for Patient Recruitment Business | MT |
Sales 2022 | 902K 589K | Sales 2023 | 618K 404K | Capitalization | 1.76M 1.15M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.31M | Net income 2023 | -1M -653K | EV / Sales 2022 | 1.96 x |
Net cash position 2022 | 786K 514K | Net cash position 2023 | 153K 99.86K | EV / Sales 2023 | 2.6 x |
P/E ratio 2022 |
-1.23
x | P/E ratio 2023 |
-1.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 68.48% |
1 day | -23.81% | ||
1 week | -15.79% | ||
Current month | -38.46% | ||
1 month | -27.27% | ||
3 months | -50.00% | ||
6 months | -63.64% | ||
Current year | -42.86% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Jain
CEO | Chief Executive Officer | - | Nov. 23 |
Marc Angelone
FOU | Founder | - | 94-01-16 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
BRD | Director/Board Member | 54 | 23-09-03 |
Mark Ziirsen
CHM | Chairman | 61 | 20-09-20 |
Antanas Guoga
BRD | Director/Board Member | 50 | 23-09-03 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.016 | -23.81% | 1,160,136 |
24-04-24 | 0.021 | +23.53% | 248,739 |
24-04-23 | 0.017 | -10.53% | 3,861,323 |
24-04-22 | 0.019 | 0.00% | 370,400 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-42.86% | 1.77M | |
+4.36% | 32.47B | |
+14.14% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.17B | |
-25.96% | 1.28B | |
-36.14% | 1.09B | |
-35.42% | 902M | |
-0.13% | 893M | |
-24.12% | 857M |
- Stock Market
- Equities
- OPL Stock